Member Exclusive

Mass spectrometry reveals incorrect drug binding in anti-HIV drugs

Researchers from the University of Oxford (UK) have used mass spectrometry to demonstrate incorrect protein binding in anti-HIV protein inhibitor drugs, which results in unwanted side effects.

Go to the profile of Peter Brown
Aug 31, 2016

Please sign in or register for FREE

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.



Go to the profile of Stella Bennett
Stella Bennett over 1 year ago

It's great that more research is being done into the efficacy of anti-HIV drugs. Any therapeutic for a chronic condition should have as few side effects as possible! Could also have important implications for future drug design.